Trial intelligence / Profile preview

ADACEL POLIO as Fifth Dose in Healthy Children in Taiwan

NCT00797511Phase 3Completed

Sponsor
Sanofi
Start
Nov 2008
Primary completion
Apr 2009
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of Adacel Polio in diphtheria, Tetanus, pertussis, poliomyelitis, sponsored by Sanofi. Started Nov 2008; status: completed.

02

Drugs

Adacel Polio
03

Conditions

diphtheriaTetanuspertussispoliomyelitis

Beyond the preview

Go deeper on NCT00797511.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00797511.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call